SAGE Therapeutics Inc
NASDAQ:SAGE
SAGE Therapeutics Inc
NASDAQ:SAGE
Price:
8.68
USD
Market Closed
Market Cap:
$544.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SAGE Therapeutics Inc
NASDAQ:SAGE
|
US |
|
Edreams Odigeo SA
MAD:EDR
|
ES |
|
T
|
Tanco Holdings Bhd
KLSE:TANCO
|
MY |
|
A
|
Abans Holdings Ltd
NSE:AHL
|
IN |
|
Trelleborg AB
STO:TREL B
|
SE |
|
A
|
ALD SA
PAR:ALD
|
FR |
|
J
|
Jiangsu Hongdou Industrial Co Ltd
SSE:600400
|
CN |
|
Parag Milk Foods Ltd
NSE:PARAGMILK
|
IN |
|
General Elevator Co Ltd
SZSE:300931
|
CN |
|
G
|
GE Vernova LLC
NYSE:GEV
|
US |
|
KEC Corp
KRX:092220
|
KR |
|
P
|
Primotec Group Ltd
TASE:PRMG
|
IL |
|
Descente Ltd
TSE:8114
|
JP |
|
Espressif Systems Shanghai Co Ltd
SSE:688018
|
CN |
|
Pinnacle Investment Management Group Ltd
ASX:PNI
|
AU |
|
CogState Ltd
ASX:CGS
|
AU |
|
CohBar Inc
OTC:CWBR
|
US |
|
Aspinwall & Co Ltd
NSE:ASPINWALL
|
IN |
|
Hyosung Advanced Materials Corp
KRX:298050
|
KR |
|
E
|
Echeverria Izquierdo SA
SGO:EISA
|
CL |
Balance Sheet
Balance Sheet Decomposition
SAGE Therapeutics Inc
SAGE Therapeutics Inc
Balance Sheet Decomposition is not available for
SAGE Therapeutics Inc
SAGE Therapeutics Inc
Balance Sheet
SAGE Therapeutics Inc
SAGE Therapeutics Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
3
|
8
|
128
|
187
|
169
|
306
|
191
|
127
|
1 661
|
294
|
163
|
71
|
81
|
|
| Cash Equivalents |
3
|
8
|
128
|
187
|
169
|
306
|
191
|
127
|
1 661
|
294
|
163
|
71
|
81
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
229
|
213
|
732
|
882
|
439
|
1 448
|
1 110
|
682
|
423
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
14
|
89
|
13
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
14
|
89
|
13
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
5
|
6
|
22
|
27
|
23
|
40
|
51
|
26
|
14
|
|
| Total Current Assets |
3
|
8
|
129
|
189
|
403
|
525
|
945
|
1 035
|
2 122
|
1 801
|
1 337
|
869
|
531
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
4
|
6
|
43
|
32
|
19
|
13
|
6
|
12
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
4
|
6
|
43
|
32
|
19
|
13
|
6
|
12
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
5
|
7
|
5
|
6
|
7
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
1
|
1
|
2
|
6
|
5
|
6
|
6
|
7
|
4
|
|
| Total Assets |
3
N/A
|
9
+183%
|
130
+1 426%
|
189
+46%
|
405
+114%
|
530
+31%
|
953
+80%
|
1 084
+14%
|
2 159
+99%
|
1 825
-15%
|
1 356
-26%
|
882
-35%
|
547
-38%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
2
|
2
|
5
|
13
|
9
|
34
|
15
|
4
|
11
|
19
|
10
|
13
|
|
| Accrued Liabilities |
0
|
0
|
1
|
3
|
6
|
16
|
20
|
33
|
24
|
27
|
38
|
64
|
44
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
4
|
7
|
16
|
27
|
32
|
64
|
40
|
48
|
43
|
9
|
15
|
|
| Total Current Liabilities |
1
|
2
|
8
|
15
|
35
|
52
|
86
|
112
|
67
|
85
|
99
|
83
|
72
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
3
|
4
|
27
|
20
|
11
|
5
|
0
|
11
|
|
| Total Liabilities |
1
N/A
|
2
+71%
|
8
+225%
|
15
+96%
|
36
+135%
|
55
+51%
|
90
+65%
|
140
+56%
|
87
-38%
|
96
+11%
|
104
+8%
|
83
-20%
|
82
-1%
|
|
| Equity | ||||||||||||||
| Common Stock |
15
|
38
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
32
|
67
|
161
|
320
|
590
|
963
|
1 644
|
1 038
|
1 495
|
2 028
|
2 570
|
2 970
|
|
| Additional Paid In Capital |
0
|
0
|
189
|
335
|
689
|
1 066
|
1 827
|
2 587
|
3 110
|
3 228
|
3 291
|
3 370
|
3 436
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
10
|
1
|
0
|
|
| Total Equity |
2
N/A
|
6
+288%
|
122
+1 866%
|
174
+42%
|
369
+112%
|
476
+29%
|
863
+81%
|
945
+9%
|
2 072
+119%
|
1 729
-17%
|
1 253
-28%
|
800
-36%
|
465
-42%
|
|
| Total Liabilities & Equity |
3
N/A
|
9
+183%
|
130
+1 426%
|
189
+46%
|
405
+114%
|
530
+31%
|
953
+80%
|
1 084
+14%
|
2 159
+99%
|
1 825
-15%
|
1 356
-26%
|
882
-35%
|
547
-38%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
24
|
24
|
26
|
29
|
37
|
42
|
47
|
52
|
58
|
59
|
60
|
60
|
61
|
|
Switch to:
Switch to:
See Also
Discover More
